Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?

Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Kildare, Ireland. National Children's Research Centre, Dublin, Ireland. Trinity Translational Medicine Institute, Department of Surgery, St James's Hospital, Dublin, Ireland. Trinity St James's Cancer Institute, St James's Hospital Dublin, Dublin, Ireland. Obesity Immunology Group, Education and Research Centre, St Vincent's University Hospital, University College, Dublin, Ireland.

European journal of immunology. 2020;(8):1098-1108
Full text from:

Abstract

Mucosal associated invariant T (MAIT) cells are a population of evolutionarily conserved T cells, which express an invariant T cell receptor (TCR) and represent a significant subset of innate-like T cells in humans, yet their role in immunity is still emerging. Unlike conventional αβ T cells, MAIT cells are not restricted by MHC molecules, but instead uniquely recognize microbially derived vitamin metabolites presented by the MHC-I like molecule MR1. MAIT cells are enriched in mucosal sites and tissues including liver and adipose tissue where they are thought to play an important role in immunosurveillance and immunity against microbial infection. In addition to their putative role in antimicrobial immunity, recent research on MAIT cells, in particular IL-17 producing MAIT cells, has demonstrated their involvement in numerous chronic inflammatory conditions. In this review, we give an overview of the work to date on the function and subsets of MAIT cells. We also examine the role of IL-17 producing MAIT cells in chronic inflammatory diseases ranging from autoimmune conditions, metabolic diseases to cancer. Furthermore, we discuss the most recent findings from the clinic that might help deepen our understanding about the biology of MAIT cells.

Methodological quality

Publication Type : Review

Metadata

MeSH terms : Inflammation ; Interleukin-17